Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FHF12
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,676
Award facts
- Contract value 100% obligated
- $13,675.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,675.68 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with a completion date of June 2, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Dupixent (dupilumab) is a biologic medication used primarily for treating moderate-to-severe eczema, asthma, and chronic rhinosinusitis, making this award part of the company's broader portfolio delivering specialty medications and brand-name pharmaceuticals across multiple therapeutic domains to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FHF12?
SPE2DB25FHF12 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FHF12 worth?
The government has obligated $13,676 on SPE2DB25FHF12.
Is contract SPE2DB25FHF12 an order under another contract?
Yes. SPE2DB25FHF12 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHF12 competed?
The extent of competition for SPE2DB25FHF12 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award